Atomistry » Iodine » PDB 5kkg-5nfi » 5mhp
Atomistry »
  Iodine »
    PDB 5kkg-5nfi »
      5mhp »

Iodine in PDB 5mhp: Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity

Enzymatic activity of Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity

All present enzymatic activity of Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity:
3.1.4.39;

Protein crystallography data

The structure of Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity, PDB code: 5mhp was solved by D.Fleury, I.Mueller, M.Lamers, N.Triballeau, P.Mollat, L.Vercheval, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 75.87 / 2.43
Space group P 1 21 1
Cell size a, b, c (Å), α, β, γ (°) 77.230, 79.530, 79.740, 90.00, 100.78, 90.00
R / Rfree (%) 20.7 / 24.5

Other elements in 5mhp:

The structure of Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity also contains other interesting chemical elements:

Fluorine (F) 1 atom
Magnesium (Mg) 1 atom
Zinc (Zn) 2 atoms
Calcium (Ca) 1 atom
Chlorine (Cl) 3 atoms

Iodine Binding Sites:

The binding sites of Iodine atom in the Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity (pdb code 5mhp). This binding sites where shown within 5.0 Angstroms radius around Iodine atom.
In total only one binding site of Iodine was determined in the Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity, PDB code: 5mhp:

Iodine binding site 1 out of 1 in 5mhp

Go back to Iodine Binding Sites List in 5mhp
Iodine binding site 1 out of 1 in the Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity


Mono view


Stereo pair view

A full contact list of Iodine with other atoms in the I binding site number 1 of Novel Imidazo[1,2-A]Pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity within 5.0Å range:
probe atom residue distance (Å) B Occ
A:I913

b:45.3
occ:1.00
N A:ASN231 3.5 30.2 1.0
NH1 A:ARG392 3.8 36.2 1.0
CA A:GLY230 3.8 28.2 1.0
N A:SER232 4.0 33.9 1.0
CE A:LYS209 4.0 35.3 1.0
C A:GLY230 4.1 29.1 1.0
O A:SER232 4.2 34.9 1.0
CG1 A:VAL386 4.3 35.4 1.0
CD2 A:LEU390 4.3 39.8 1.0
CG A:LYS209 4.3 32.6 1.0
CB A:ASN231 4.4 32.2 1.0
CA A:ASN231 4.4 31.7 1.0
CD1 A:LEU390 4.5 39.4 1.0
CD A:LYS209 4.7 33.6 1.0
CG A:LEU390 4.7 38.2 1.0
C A:ASN231 4.7 32.6 1.0
CB A:SER232 4.8 37.3 1.0
CA A:SER232 4.9 35.6 1.0
CZ A:ARG392 4.9 35.6 1.0

Reference:

N.Desroy, C.Housseman, X.Bock, A.Joncour, N.Bienvenu, L.Cherel, V.Labeguere, E.Rondet, C.Peixoto, J.M.Grassot, O.Picolet, D.Annoot, N.Triballeau, A.Monjardet, E.Wakselman, V.Roncoroni, S.Le Tallec, R.Blanque, C.Cottereaux, N.Vandervoort, T.Christophe, P.Mollat, M.Lamers, M.Auberval, B.Hrvacic, J.Ralic, L.Oste, E.Van Der Aar, R.Brys, B.Heckmann. Discovery of 2-[[2-Ethyl-6-[4-[2-(3-Hydroxyazetidin-1-Yl) -2-Oxoethyl]Piperazin-1-Yl]-8-Methylimidazo[1, 2-A]Pyridin-3-Yl]Methylamino]-4-(4-Fluorophenyl) Thiazole-5-Carbonitrile (GLPG1690), A First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation For the Treatment of Idiopathic Pulmonary Fibrosis. J. Med. Chem. V. 60 3580 2017.
ISSN: ISSN 1520-4804
PubMed: 28414242
DOI: 10.1021/ACS.JMEDCHEM.7B00032
Page generated: Sun Dec 13 19:40:19 2020

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy